Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC Dec 29, 2023 04:16PM

Form 144 ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC Dec 27, 2023 05:03PM

Form 144 ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC Dec 27, 2023 05:01PM

Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC Nov 13, 2023 08:55AM

Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC Sep 27, 2022 04:29PM

Nov 12, 2021 05:06PM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Dec 30, 2020 04:44PM Form 4 ALPINE IMMUNE SCIENCES, For: Dec 28 Filed by: ORBIMED ADVISORS LLC
Dec 30, 2020 04:27PM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Jul 30, 2020 06:26PM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
May 9, 2019 07:25AM Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2019 Financial Results
Mar 18, 2019 07:30AM Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2018 Financial Results
Jan 23, 2019 05:59PM Form 4 ALPINE IMMUNE SCIENCES, For: Jan 18 Filed by: ORBIMED ADVISORS LLC
Jan 23, 2019 05:21PM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Jan 16, 2019 07:02AM Alpine Immune Sciences (ALPN) Announces $25 Million Private Placement of Common Stock and Warrants
Jan 16, 2019 07:00AM Alpine Immune Sciences Announces $25 Million Private Placement
Mar 28, 2018 07:00AM Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2017 Financial Results
Jan 26, 2018 12:23PM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 06:04AM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Nov 13, 2017 04:05PM Alpine Immune Sciences Reports Corporate Update and Third Quarter 2017 Financial Results
Aug 3, 2017 02:17PM Form SC 13D ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Jul 25, 2017 06:30AM Alpine Immune Sciences, Inc. Completes Merger with Nivalis Therapeutics, Inc.

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed